Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CEO INTERVIEW: CORINNE LYLE - TULARIK INC (TLRK).


(PAL217) CORINNE LYLE - TULARIK INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
 (TLRK). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Biotechnology. Published date 6/2/02. Tickers featured: TLRK. Complete text approximately 3000 words. Document # PAL217.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2002 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:CEO INTERVIEW: CORINNE LYLE - TULARIK INC (TLRK).(Brief Article)
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 10, 2002
Words:88
Previous Article:CEO INTERVIEW: CHARLES CASAMENTO - QUESTCOR PHARMACEUTICALS INC (QSC).
Next Article:CEO INTERVIEW: ARTHUR SANDS - LEXICON GENETICS INC (LEXG).
Topics:



Related Articles
Tularik Appoints Corinne H. Lyle As Chief Financial Officer.
DAVID V. GOEDDEL - TULARIK INC (TLRK).
Tularik to Host International Biotechnology Event April 17th; Joins With U.S. Commercial Service to Help Forge Multinational Biotech Business Ties.
CEO INTERVIEW: LYLE BERMAN - LAKES GAMING INC (LACO).
Tularik Announces Departure of Andrew J. Perlman, EVP.
Tularik Provides Mid-Year Update at the 23rd Annual Goldman Sachs Healthcare Conference.
Tularik to Present at the 12th Annual Wachovia Securities Nantucket Equity Conference.
TULARIK BEGINS PHASE 1 CLINICAL TRIAL OF ANTI-INFLAMMATORY.
AMGEN, TULARIK ENTER INTO DEAL RIGHTS GAINED FOR CANCER DRUGS.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles